MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Lifesciences | Healthcare & Wellness

MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Market by Drug Class, Application, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton's research report, the Middle East and African dermatological therapeutics market would surge with a CAGR of 7.47% in the forecasting years of 2019-2028.


Report scope can be customized per your requirements. Request For Customization

The countries reviewed in this market include:

•           Saudi Arabia

•           The United Arab Emirates

•           Turkey

•           South Africa

•           Rest of MEA

The presence of several international derma-health companies and a flourishing medical tourism industry are factors attracting numerous investors and patients to the MEA region, especially the UAE and Saudi Arabia. Though, due to the COVID-19 outbreak this year, the medical tourism industry has been at its lowest point, this situation is expected to improve gradually, thereby putting the region’s dermatological therapeutics market back on the growth track in the forecasting period.

In Saudi Arabia, a five-year retrospective study published in the Journal of Dermatology and Dermatological Surgery by Fawwaz Al Shammrie, in 2017, suggests that, eczema is the most commonly occurring dermatological disease in the country. Further, there is also a high rate of incidence of acne, atopic dermatitis, alopecia, and psoriasis, among others. 

Moreover, the renowned pharmaceutical R&D company, AbbVie, organized a "Best of the American Academy of Dermatology" event in Saudi Arabia in 2019. It was learnt that, several Saudi-based patients, who have psoriasis, reported the disease to have majorly hampered their quality of life. There were an estimated 500,000 patients affected by psoriasis at the time, with one-third of these cases ranging from moderate to severe. The high prevalence of dermatological diseases in the KSA has significantly enhanced the demand for dermatological treatments and therapeutics. This, along with the growth in the country’s geriatric population, is propelling Saudi’s dermatological therapeutics market to expand in the coming years.

Merck & Co develops, manufactures, and markets pharmaceutical and biological prescription drugs for the treatment of various health conditions. The company has strong research and development (R&D) capabilities. Its RonaCare range offers creams for various skin health issues. Merck has a notable business presence in the Middle East and Africa.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1.   ADVANCEMENTS IN BIOLOGICS

2.2.2.   ATOPIC DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTE

2.3.3.   BARGAINING POWER OF SUPPLIERS

2.3.4.   BARGAINING POWER OF BUYERS

2.3.5.   THREAT OF COMPETITIVE RIVALRY

2.4. IMPACT OF COVID-19 – DERMATOLOGICAL THERAPEUTICS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. MARKET DRIVERS

2.7.1.   INCREASING BURDEN OF DERMATOLOGICAL DISEASES

2.8. MARKET RESTRAINTS

2.8.1.   GRAVE SIDE-EFFECTS FOR CERTAIN CLASSES OF THERAPEUTIC DRUGS

2.9. MARKET OPPORTUNITIES

2.9.1.   RISE IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION

2.10. MARKET CHALLENGES

2.10.1.                UNAWARENESS TOWARDS DERMATOLOGICAL DIAGNOSIS

3. MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK – BY DRUG CLASS

3.1. ANTI-INFECTIVES

3.2. CORTICOSTEROIDS

3.3. ANTI-ACNE

3.4. CALCINEURIN INHIBITORS

3.5. RETINOIDS

3.6. OTHER DRUG CLASSES

4. MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION

4.1. ALOPECIA

4.2. HERPES

4.3. PSORIASIS

4.4. ROSACEA

4.5. ATOPIC DERMATITIS

4.6. ACNE VULGARIS

4.7. OTHER APPLICATIONS

5. MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK

5.1. MIDDLE EAST AND AFRICA

5.1.1.   UNITED ARAB EMIRATES

5.1.2.   TURKEY

5.1.3.   SAUDI ARABIA

5.1.4.   SOUTH AFRICA

5.1.5.   REST OF MIDDLE EAST & AFRICA

6. COMPETITIVE LANDSCAPE

6.1. ABBVIE INC

6.2. ALLERGAN

6.3. ALMIRALL

6.4. AMGEN INC

6.5. BAUSCH HEALTH COMPANIES INC

6.6. GALDERMA

6.7. GLAXOSMITHKLINE PLC

6.8. JOHNSON & JOHNSON

6.9. NOVARTIS AG

6.10. PFIZER INC

6.11. AGI DERMATICS

6.12. LEO PHARMA A/S

6.13. MERCK & CO

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of table

TABLE 1: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 2: MARKET ATTRACTIVENESS INDEX

TABLE 3: VENDOR SCORECARD

TABLE 4: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 5: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 6: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $ BILLION)

FIGURE 3: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ BILLION)

FIGURE 4: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)

FIGURE 5: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ BILLION)

FIGURE 6: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)

FIGURE 7: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)

FIGURE 8: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)

FIGURE 9: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)

FIGURE 10: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)

FIGURE 11: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)

FIGURE 12: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $ BILLION)

FIGURE 13: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)

FIGURE 14: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ BILLION)

FIGURE 15: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 16: UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 17: TURKEY DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 18: SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 19: SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 20: REST OF MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;